Virginia · 2026 Regular Session · Bill

SB 641: Office-based buprenorphine treatment; Board of Medicine to amend regulations.

Enacted Last action April 6, 2026: Acts of Assembly Chapter text (CHAP0208)

Plain-language summary

SB 641 is a bill introduced in the Virginia Senate on January 14, 2026. According to its official title, it concerns: Office-based buprenorphine treatment; Board of Medicine to amend regulations. Primary sponsor: Todd Pillion (Republican). It lists 12 additional sponsors. Most recent recorded action (April 6, 2026): Acts of Assembly Chapter text (CHAP0208).

Sponsors

Primary sponsor: Todd Pillion (Republican). 12 co-sponsors.